Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-017-1966-2
Abstract: Immunotherapies emerged as an alternative for cancer treatment, yet their clinical efficacies are still limited, especially in case of solid tumors. Myeloid immune cells, such as macrophages and myeloid-derived suppressor cells (MDSCs), are often hijacked… read more here.
Keywords: myeloid cells; oligonucleotide therapeutics; stat3; cancer ... See more keywords